Amid persistent demand and cutting-edge developments, the biotech industry has evolved and flourished over the past few decades. As the industry continues to thrive, fundamentally strong biotech stocks Gilead Sciences, Inc. (GILD), Incyte Corporation (INCY), and Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) could soar high in the coming months.
Despite the uncertain economic backdrop, the biotech industry should remain steady due to the inelastic demand for healthcare products and services. Additionally, attractive government initiatives, such as President Biden’s National Biotechnology and Biomanufacturing Initiative, have the potential to boost the industry’s growth.
